サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：診断学における人工知能（AI）の世界市場：2023-2030年
市場調査レポート
商品コード
1350992

診断学における人工知能（AI）の世界市場：2023-2030年

Global Artificial Intelligence (AI) in Diagnostics Market 2023-2030

出版日
ページ情報
英文 155 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
診断学における人工知能（AI）の世界市場：2023-2030年
出版日: 2023年08月20日
発行: Orion Market Research
ページ情報: 英文 155 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のAI診断市場は、予測期間中（2023-2030年）にCAGR 23.5%で成長すると予測されています。市場の拡大は、世界のヘルスケア費用の削減が原動力となっています。病気の早期発見のためのAIの導入は、大幅な財政節約に貢献します。早期発見は高価な治療の必要性を減らし、病気の進行を妨げる可能性があるからです。そのようにAI技術を採用することで、医療費も削減できます。

この傾向に伴い、業界の利害関係者は、AIベースの疾患検出ソリューションに対する需要の高まりに対応するため、斬新な製品を導入しています。例えば、2023年5月、AegisとNorthwellは共同で、AIを活用した疾患検出のためのObtainを1,200万米ドルで立ち上げました。ObtainはAscertainの発案によるもので、Ascertainを導入した最初の企業でもあります。Ascertainは、Aegis VenturesとNorthwell Holdingsのジョイントベンチャーとして2022年に1億米ドルで立ち上げた企業創造プラットフォームです。Ascertainsの今後のプロジェクトは、ヘルスケアへのアクセスを向上させ、提供されるケアの質を高めるために、AIの可能性に参加することに特化して展開されます。Obtainに関しては、患者の目の画像のみから病気の初期兆候を特定するAIツールです。

セグメント別の展望

診断における人工知能（AI）の世界市場では、神経学サブセグメントがかなりのシェアを占めると予想されます。

アプリケーションの中でも、神経学のサブセグメントが診断における人工知能の世界市場でかなりのシェアを占めると予想されています。神経科医は、脳、脊髄、神経に影響を及ぼす疾患の特定と治療に重点を置く医師です。一般的な神経学的疾患と難解な神経学的疾患の両方を考慮し、症状の原因の特定と治療戦略の立案を支援することができます。神経学的検査では、ライトや反射ハンマーなどの器具を使用して神経系を評価することができます。AIベースのツールは医療を変革する可能性を秘めており、より迅速で正確な診断、個別化された治療計画、新たな治療アプローチ、効果的な疾患モニタリングを可能にします。したがって、市場成長を支える主な要因には、より精密で正確な診断と結果に対する世界の需要の高まりが含まれます。神経画像データは、AIアルゴリズムを使って分析することで、人間の目では見落としがちな異常やパターンを特定することができます。これにより、より早く、より正確な診断が可能となり、市場関係者が神経疾患の診断のためのAIベースのソリューションを開発することをさらに後押ししています。例えば、2023年4月、TeraReconはAI-Powered Neuro Suiteを発売しました。放射線技師は、Neuro Suiteプラットフォームを使用して、Combinostics、Imaging Biometrics、Cercare Medicalなどの神経学のトップサプライヤーが提供する多数のAI搭載神経画像モダリティを利用することができます。

地域別展望

世界の人工知能診断市場は、北米（米国とカナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。このうち、アジア太平洋地域は、AIベースの診断ソリューションの利用を促進するための公的・民間イニシアチブの増加により、世界全体で顕著な市場シェアを占めると予想されます。さらに、投資と意識の高まりとともに起業家の開拓が、この地域市場の拡大を促進しています。

診断における人工知能の世界市場において北米地域が大幅なCAGRで成長する見込み

すべての地域の中で、北米は予測期間中にかなりのCAGRで成長すると予想されています。この地域の成長は、同国内の慢性疾患の有病率の上昇とヘルスケアシステムにおける先端技術の統合の拡大に起因しています。診断におけるAIは、膨大な医療データの分析をナビゲートする潜在的なツールとして浮上しており、慢性疾患の早期発見と個別化された治療法の開発につながります。

地域全体で慢性疾患の有病率が高まっていることが、市場拡大に有利な環境を作り出しています。例えば、2022年1月に米国がん協会が発表したところによると、米国では新たに約190万人のがん患者が診断されると予測されています。そのうち、前立腺がん症例は186,670件、肺がん症例は169,870件、女性乳がん症例は144,490件に達すると予測されています。がんやその他の慢性疾患の有病率が上昇するにつれ、正確な診断と治療の重要性が増しています。このような動きにより、早期診断のためのAIの活用が促進され、市場の成長が期待されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • AliveCor, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • GE HealthCare Technologies Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Siemens Healthineers
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 診断における人工知能（AI）の世界市場：タイプ別
    • 体外診断
    • 画像診断
  • 診断における人工知能（AI）の世界市場：用途別
    • 心臓病学
    • 腫瘍学
    • 神経学
    • 産婦人科
    • その他（眼科、専門医、放射線科）
  • 診断における人工知能（AI）の世界市場：エンドユーザー別
    • 病院
    • 画像診断センター
    • 診断研究所

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Aidoc Medical Ltd.
  • Digital Diagnostics Inc.
  • IMAGEN
  • InformAI, LLC
  • Nano-x Imaging Ltd.
  • Northwell Health
  • NovaSignal Corp.
  • Riverain Technologies
  • Silicon Mechanics
  • VUNO Inc.
図表

LIST OF TABLES

  • 1. GLOBAL AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL AI IN VITRO DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL AI IN DIAGNOSTIC IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL AI IN DIAGNOSTICS FOR CARDIOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 6. GLOBAL AI IN DIAGNOSTICS FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 7. GLOBAL AI IN DIAGNOSTICS FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL AI IN DIAGNOSTICS FOR OBSTETRICS AND GYNECOLOGY MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL AI IN DIAGNOSTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 10. GLOBAL AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL AI IN DIAGNOSTICS FOR HOSPITALS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 12. GLOBAL AI IN DIAGNOSTICS FOR DIAGNOSTICS IMAGING CENTERS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 13. GLOBAL AI IN DIAGNOSTICS FOR DIAGNOSTICS LABORATORIES MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 14. GLOBAL AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD AI IN DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL AI IN DIAGNOSTICS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL AI IN VITRO DIAGNOSTICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL AI IN DIAGNOSTIC IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL AI IN DIAGNOSTICS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL AI IN DIAGNOSTICS FOR CARDIOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AI IN DIAGNOSTICS FOR ONCOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL AI IN DIAGNOSTICS FOR NEUROLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL AI IN DIAGNOSTICS FOR OBSTETRICS AND GYNECOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL AI IN DIAGNOSTICS FOR OTHER APPLICATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL AI IN DIAGNOSTICS MARKET SHARE ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL AI IN DIAGNOSTICS FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL AI IN DIAGNOSTICS FOR DIAGNOSTICS IMAGING CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL AI IN DIAGNOSTICS FOR DIAGNOSTICS LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL AI IN DIAGNOSTICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD AI IN DIAGNOSTICS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027586

Title: Global Artificial Intelligence (AI) in Diagnostics Market Size, Share & Trends Analysis Report by Type (Vitro Diagnostics, and Diagnostic Imaging), by Application (Cardiology, Oncology, Neurology, Obstetrics and Gynecology, and Others), and by End User (Hospitals, Diagnostics Imaging Centers, and Diagnostics Laboratories),Forecast Period (2023-2030).

The global AI in diagnostics market is anticipated to grow at a CAGR of 23. 5% during the forecast period (2023-2030). The expansion of the market is driven by the global reduction in healthcare expenses. The implementation of AI for early disease detection contributes to significant financial savings. As the early detection has the potential to reduce the necessity for expensive therapies and can hamper the progression of diseases. Medical costs can also be reduced by employing AI technology in that manner.

In line with this trend, industry stakeholders are introducing novel offerings to meet the growing demand for AI-based disease detection solutions. For instance, in May 2023, Aegis and Northwell collaboratively launched Obtain with $12 million for AI-powered disease detection. Obtain is the brainchild of Ascertain, which is also the first company to introduce Ascertain. Ascertain is a company creation platform that launched in 2022 with $100 million as a joint venture between Aegis Ventures and Northwell Holdings. Ascertains upcoming projects will revolve exclusively around joining the potential of AI to enhance healthcare accessibility and elevate the caliber of care provided. As far as Obtain is concerned, it is an AI tool which will identify initial indications of diseases solely through images of a patient's eye.

Segmental Outlook

The global AI in diagnostics Market is segmented by type, application, and end-user. Based on type, the market is sub-segmented into in vitro diagnostics and diagnostic imaging. Based on the application, the market is sub-segmented into cardiology, oncology, neurology, obstetrics and gynecology, and others. Further, on the basis of end user, the market is sub-segmented into hospitals, diagnostic imaging centers, and diagnostic laboratories. Among the type segment, the in vitro diagnostics sub-segment is anticipated to hold a considerable share of the market owing to the fact that the medical and healthcare industries are increasingly utilizing AI solutions to reduce the potential for human errors and enhance treatment outcomes.

The Neurology Sub-Segment is Anticipated to Hold a Considerable Share of the Global Artificial Intelligence (AI) in Diagnostics Market

Among the applications, the neurology sub-segment is expected to hold a considerable share of the global artificial intelligence in diagnostics market. A neurologist is a physician who focuses on identifying and treating diseases affecting the brain, spinal cord, and nerves. Considering both common and difficult neurological diseases, they can assist in determining the cause of symptoms and developing a treatment strategy. Instruments, including lights and reflex hammers, can be used during a neurological exam to evaluate the nervous system. AI-based tools have the potential to transform health care, enabling faster and more accurate diagnosis, personalized treatment plans, new therapeutic approaches and effective disease monitoring. Thus, the primary factor supporting the market growth includes the increased demand for more precise and accurate diagnosis and results, globally. Neuroimaging data can be analyzed using AI algorithms to identify abnormalities and patterns that the human eye can overlook. This can result in earlier and more precise diagnoses, further propelling market players to develop AI-based solutions for diagnosing neurological disorders. For instance, in April 2023, TeraRecon launched the AI-Powered Neuro Suite. Radiologists can utilize a number of AI-powered neuroimaging modalities from top neurology suppliers, such as Combinostics, Imaging Biometrics, and Cercare Medical, using the Neuro Suite platform.

Regional Outlook

The global artificial intelligence in diagnostics market is further segmented based on geography, including North America (the US and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and the Rest of Asia), and the Rest of the World (the Middle East and Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increased public and private initiatives to promote the use of AI-based diagnostic solutions. Additionally, the development of entrepreneurs along with the growing investment and awareness have promoted the expansion of the regional market.

The North America Region is Expected to Grow at a Significant CAGR in the Global Artificial Intelligence in Diagnostics Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. The regional growth is attributed to the rising prevalence of chronic diseases within the country and the expanding integration of advanced technology in healthcare systems. AI in Diagnostics has emerged as a potential tool to navigate the analysis of extensive medical data, leading to the early detection of chronic diseases and the capacity to develop individualized treatments.

The increasing prevalence of chronic diseases across the region has created a favorable environment for market expansion. For instance, in January 2022, the American Cancer Society reports that the US is projected to witness the diagnosis of approximately 1.9 million new cancer cases. Out of which, prostate cancer cases are projected to reach 186,670, lung cancer cases to total 169,870, and female breast cancer cases to amount 144,490 in the upcoming year. Accurate diagnosis and treatment have grown more important as the prevalence of cancer and other chronic diseases rises. It is anticipated that such actions can promote the utilization of AI for early diagnosis, resulting in market growth.

Market Players Outlook

The major companies serving the AI in diagnostics market include: Aidoc Medical Ltd., Digital Diagnostics Inc., IMAGEN, InformAI, LLC, Nano-x Imaging Ltd., and others. The market players are considerably contributing to market growth through the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022, Indica Labs and The Industrial Centre for AI Research in Digital Diagnostics (iCAIRD) signed an agreement to collaborate on creating a digital pathology system powered by AI that can identify cancer in lymph nodes after colorectal surgery.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global AI in diagnostics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. AliveCor, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GE HealthCare Technologies Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Siemens Healthineers
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Artificial Intelligence (AI) in Diagnostics Market by Type
    • 4.1.1. Vitro Diagnostics
    • 4.1.2. Diagnostic Imaging
  • 4.2. Global Artificial Intelligence (AI) in Diagnostics Market by Application
    • 4.2.1. Cardiology
    • 4.2.2. Oncology
    • 4.2.3. Neurology
    • 4.2.4. Obstetrics and Gynecology
    • 4.2.5. Others (Ophthalmology, Specialty, Radiology)
  • 4.3. Global Artificial Intelligence (AI) in Diagnostics Market by End User
    • 4.3.1. Hospitals
    • 4.3.2. Diagnostics Imaging Centers
    • 4.3.3. Diagnostics Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aidoc Medical Ltd.
  • 6.2. Digital Diagnostics Inc.
  • 6.3. IMAGEN
  • 6.4. InformAI, LLC
  • 6.5. Nano-x Imaging Ltd.
  • 6.6. Northwell Health
  • 6.7. NovaSignal Corp.
  • 6.8. Riverain Technologies
  • 6.9. Silicon Mechanics
  • 6.10. VUNO Inc.